161 related articles for article (PubMed ID: 36464880)
1. Radiopharmaceutical Encapsulated Liposomes as a Novel Radiotracer Im - aging and Drug Delivery Protocol.
Alkandari AM; Alsayed YM; El-Hanbaly AM
Curr Radiopharm; 2023; 16(2):133-139. PubMed ID: 36464880
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Efficacy of Radiopharmaceuticals When Using Technetium-99m-Labeled Liposomal Agents: Synthesis and Pharmacokinetic Properties.
Alkandari AM; Alsayed YM; El-Hanbaly AM
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428563
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
Belhaj-Tayeb H; Briane D; Vergote J; Kothan S; Léger G; Bendada SE; Tofighi M; Tamgac F; Cao A; Moretti JL
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):502-9. PubMed ID: 12536243
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
[TBL] [Abstract][Full Text] [Related]
6. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
Goins B; Bao A; Phillips WT
Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
[TBL] [Abstract][Full Text] [Related]
7. Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
Cordobes MD; Moretti JL; de Beco V; Benazzouz F; Starzec A
Nucl Med Commun; 1999 May; 20(5):433-7. PubMed ID: 10404528
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Assessment of
Alkandari AM; Shafaa MW; Alsayed YM
J Nucl Med Technol; 2020 Sep; 48(3):269-273. PubMed ID: 32518123
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. (99m)Tc-YIGSR as a receptor tracer in imaging the Ehrlich ascites tumor-bearing mice as compared with (99m)Tc-MIBI.
Hu J; Qin G; Zhang Y; An R; Lan X
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):471-4. PubMed ID: 17828515
[TBL] [Abstract][Full Text] [Related]
11. A new semiquantitative method for comparing brain tumor uptake of Tc-99m sestamibi and TI-201.
San Pedro EC; Yilmaz M; Liu HG; Rosenfeld SS; Mountz JM
Clin Nucl Med; 1999 Nov; 24(11):868-73. PubMed ID: 10551470
[TBL] [Abstract][Full Text] [Related]
12. The radiotracer (99m)Tc-MIBI is not genotoxic for human peripheral blood lymphocytes at diagnostic radioactive dose.
Hosseinimehr SJ; Ahmadi A; Beiki D; Mahmoudzadeh A; Babaei M; Habibi E
Genet Mol Res; 2009 Aug; 8(3):923-8. PubMed ID: 19731214
[TBL] [Abstract][Full Text] [Related]
13. Kinetic characterization of a novel cationic (99m)Tc(I)-tricarbonyl complex, (99m)Tc-15C5-PNP, for myocardial perfusion imaging.
Liu Z; Chen L; Liu S; Barber C; Stevenson GD; Furenlid LR; Barrett HH; Woolfenden JM
J Nucl Cardiol; 2010 Oct; 17(5):858-67. PubMed ID: 20669059
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of ultrasound for preparation of (99m)Tc-sestamibi complex.
Doroudi A; Erfani M; Norouzi B; Saadati SM; Kiasat A; Ahmadi F; Etesami B; Baghersad MH
Ann Nucl Med; 2015 Apr; 29(3):295-301. PubMed ID: 25539995
[TBL] [Abstract][Full Text] [Related]
15. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy.
Goins B; Bao A; Phillips WT
Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416
[TBL] [Abstract][Full Text] [Related]
16. Does (99m)Tc-Sestamibi in high-grade malignant brain tumors reflect blood-brain barrier damage only?
Staudenherz A; Fazeny B; Marosi C; Nasel C; Hoffmann M; Puig S; Killer M; Leitha T
Neuroimage; 2000 Jul; 12(1):109-11. PubMed ID: 10875907
[TBL] [Abstract][Full Text] [Related]
17. Myocardial uptake of technetium-99m-furifosmin (Q12) versus technetium-99m-sestamibi (MIBI).
Bangard M; Bender H; Grünwald F; Hümmelgen M; Willkomm P; Palmedo H; Lüderitz B; Biersack HJ
Nuklearmedizin; 1999; 38(6):189-91. PubMed ID: 10510802
[TBL] [Abstract][Full Text] [Related]
18. Prescintigraphic morphine application for abdominal adenocarcinoma imaging, with technetium-99m methoxy isobutyl isonitrile.
Ferlitsch A; Steindl-Munda P; Haefner M; Peck-Radosavljevic M; Madl C; Pötzi R; Homoncik M; Weidekamm C; Granegger S; Sinzinger H
Hell J Nucl Med; 2007; 10(1):14-8. PubMed ID: 17450244
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.
Caveny SA; Klingensmith WC; Martin WE; Sage-El A; McIntyre RC; Raeburn C; Wolfe P
J Nucl Med Technol; 2012 Jun; 40(2):104-10. PubMed ID: 22566587
[TBL] [Abstract][Full Text] [Related]
20.
Huang Z; Lou C
J Int Med Res; 2019 Feb; 47(2):836-845. PubMed ID: 30556441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
